9 minute read
Apr. 2, 2023
pociredir: An EED1 Inhibitor for Sickle Cell Disease
pociredir
oral, allosteric PRC2 inhibitor (EED) Ph. Ib for sickle cell disease (on hold) VLS, FBLD, de novo design + opt. Press release, February 24, 2023 Fulcrum Therapeutics, Cambridge, MA